Yabao Pharmaceutical Group Co., Ltd. is the first stock listed company and the first batch of recognized high-tech enterprises in Shanxi Province, which integrates drug research and development, production, logistics, retail sales and cultivation of Chinese medicinal materials. The company has five branches, listed in 2002 A shares (stock code 600351), 13 holding subsidiaries, with nearly 7,000 employees; Yabao Pharmaceutical Industry is recognized by the Ministry of Industry and Information Technology, "China's top 100 pharmaceutical industry enterprises", innovation ranks among the top 20, is "China's pharmaceutical R&D product line of the best industrial enterprises." The trademark of "Ya Bao" is well-known trademark in China. In Beijing, Shanghai, Taiyuan, Chengdu, Guiyang, Yuncheng and other places, the company has built nine production bases, four research bases, two Chinese herbal medicine planting bases. All nine major production bases have passed the new national GMP certification, of which Beijing Biopharmaceuticals has passed the FDA cGMP certification of the United States, and three companies have passed the EU GMP certification. The main products are Chinese and Western medicine preparations, raw materials and medicinal packaging materials, a total of more than 300 varieties, mainly for elderly chronic diseases and women and children medication. Patented product Ding Guier umbilical patch is a national landmark brand product, won the first prize in science and technology of the Chinese Society of Traditional Chinese Medicine in 2014, and won the first place in the comprehensive statistical ranking of non-prescription drugs (Chinese patent medicine, pediatrics) in 2015. The company has an international research and development team, a total of 410 research and development personnel, including 22 PhD, 150 master. In the declaration, production and sales of new drugs, in line with international standards, took the "one place research and development, three places declaration; one place production, three places sales" international pace.
Group marketing center is the industrial marketing platform of Yabao Pharmaceutical Group, headquartered in Beijing Yizhuang Hi-tech Development Zone. There are more than 50 professional teams of marketing brands, and more than 3000 marketing personnel. It has established business channels, OTC retail, grass-roots terminal, hospital investment, OTC investment, raw materials and pharmaceuticals, expanded sales, North China. Beijing biology, health care consumer products and other professional marketing team. The company has a sound sales network, sales outlets cover 32 provinces and cities in the country's first, second, third-level and terminal markets, covering 661 urban districts and counties.
During the 13th Five-Year Plan period, Yabao Pharmaceutical Industry should take medicine as its main body and health products and medical services as its wings. On the one hand, Yabao Pharmaceutical Industry should cultivate deeply, on the other hand, it should borrow capital. Through the endogenous "asset management" and the extension of the "capital operation" two-wheel drive, to promote the rapid development of enterprises. By building 5 centers, we will build 10 systems, build 6 capabilities, and achieve 6 transformations. Eventually, it will become the leader of the big health industry for children, the most innovative pharmaceutical enterprise in China, and the model of internationalization of the pharmaceutical industry in China.